Skip to content
Back to blog
Research Allowance

Research Allowance Payout Germany 2026

The Research Allowance payout in Germany works differently from a classic grant. Nothing lands in the account when the project is approved. The allowance is assessed by the tax office, offset against the next tax assessment, and only the surplus is refunded. What the allowance is worth in 2026, when the money actually arrives, and where applications lose value.

Summary

  • In 2026 the Research Allowance is a predictable, non-dilutive financing instrument. SMEs generally qualify for the 35 percent rate, larger companies for 25 percent. The tax office offsets it in full against the assessed tax and refunds whatever is left over.
  • Since March 2024 the funding rate has been higher and the catalogue of eligible costs wider, and the July 2025 immediate investment programme raised the ceiling again. For expenses from 2026 the assessment basis runs to EUR 12 million per fiscal year, so an SME reaches a maximum allowance of EUR 4.2 million, which changes the arithmetic for fast-growing technology companies.
  • The cash effect does not start with the BSFZ certificate, but with the application to the tax office and the assessment that follows. Companies that line up their annual accounts, the ELSTER application and the cost documentation shorten that wait considerably.
  • Clean evidence of technological uncertainty decides how large the claim gets, together with time records, a workable contract structure for contract research, and a visible line against routine development. Many reductions come from thin documentation, not from thin ideas.
  • For startups, biotech, software, climate tech and industrial development in particular, the Research Allowance is strategically valuable: it still pays out as a refund in a loss year, and it sits comfortably alongside grants, VC or debt.

The Research Allowance payout in Germany works differently from a classic grant. No money arrives when a project is approved. The allowance is assessed, offset against the next assessment of income tax or corporate income tax, and only what exceeds that tax comes back as a refund. For founders, CFOs and R&D leads in SMEs, that distinction decides how liquidity planning and the tax calendar have to fit together.

What is the Research Allowance and who is entitled to it?

The Research Allowance is the central tax-based research funding instrument in Germany. It causes no dilution, triggers no repayment, and combines with grants, VC or bank financing. The legal basis is the Research Allowance Act (FZulG), widened by the Wachstumschancengesetz, the Growth Opportunities Act of March 2024, and again by the Investitionssofortprogramm of July 2025, the tax-based immediate investment programme, which raised the assessment basis.

The FZulG governs entitlement, the assessment basis and the assessment of the allowance itself. Alongside it stand the BMF circulars on the Research Allowance and the practice of the BSFZ, the Bescheinigungsstelle Forschungszulage, which decides the technical question of whether a project counts as R&D at all. Since March 2024 the funding rate has been higher and the catalogue of eligible costs wider; since July 2025 a higher assessment basis applies from 2026.

Which companies can apply for the Research Allowance?

Companies of any legal form qualify if they are liable to tax in Germany, registered here for tax purposes, and carry out eligible R&D. No minimum profit is required. Startups, biotech companies and deep-tech SMEs benefit most from that, because the allowance still reaches them as a tax refund in a year that closes with a loss.

Most certified projects fall into a handful of recurring patterns.

  • Software and AI with a degree of technological uncertainty
  • Biotech and pharma with experimental development
  • Automotive, mechanical engineering, climate and energy technology with systematic R&D

How high is the Research Allowance in Germany?

Funding rate and assessment basis

The Research Allowance assessment basis covers wage-tax-liable R&D personnel costs for a company's own staff that are directly allocated to a certified project. Since March 2024 certain costs for depreciable movable assets count too, along with a larger share of contract research. SMEs qualify for the increased rate of 35 percent, large companies for 25 percent.

The tax office does not accept the full invoice for contract research. Only 70 percent of the remuneration enters the assessment basis, and the date that decides is when the contract was awarded, not when the project started: contracts awarded after 27 March 2024 carry the higher share, earlier ones 60 percent. Get the contracts and the statements of work in order before the work starts, not afterwards.

Take an AI startup with 10 people on the payroll and EUR 800,000 of eligible R&D personnel costs: at 35 percent the allowance comes to EUR 280,000. If the assessed corporate income tax is only EUR 70,000, that tax falls away entirely and the remaining EUR 210,000 is refunded.

Maximum funding amount from 1 January 2026

For expenses incurred from 1 January 2026, the assessment basis for the Research Allowance runs to EUR 12 million per fiscal year. At the standard rate of 25 percent that caps the allowance at EUR 3 million; an SME claiming 35 percent reaches EUR 4.2 million. The increase comes from the tax-based immediate investment programme of July 2025, which makes every ceiling from before 2024 irrelevant for current planning.

The OECD tracks schemes like this in its R&D Tax Incentives Database, which is where the German figures can be held against other countries. The reforms of 2024 and 2025 raised both the rate and the cap, so that comparison reads differently now than it did before.

How does the payout of the Research Allowance work?

The most common misconception about the Research Allowance payout in Germany is that money moves as soon as the BSFZ certificate arrives. It does not. The BSFZ answers only the technical question. The financial effect starts with the separate application to the tax office via ELSTER and the assessment that follows it.

No direct payout to the business account

There are no interim payments and nothing is paid in advance. The tax office assesses the allowance once the application is in, as part of the tax assessment. What is possible runs the other way round: while the return for the next assessment is still outstanding and the prepayments can still be adjusted, the tax office reduces them by the assessed allowance on application, down to zero (Section 10(2a) FZulG). The Research Allowance is not a short-term cash substitute but a predictable tax-based inflow, without equity dilution, without the collateral a bank would want, and without drawdowns tied to project milestones.

Offsetting against income tax or corporate income tax

The assessed Research Allowance is offset in full against the next initial assessment of income tax or corporate income tax. For corporations that means offsetting the Research Allowance against corporate income tax, which is the standard case; partnerships and sole proprietorships see it in the income tax return. Only the amount by which the allowance exceeds that tax is paid out, so the size of the assessed tax matters as much as the size of the allowance.

In practice the sequence is short, and every step gates the next.

  • Submit the BSFZ application for the R&D project
  • After certification: document eligible costs per fiscal year
  • Once the fiscal year has ended, file the Research Allowance application with the tax office via ELSTER
  • After the tax assessment: offsetting against the tax liability, refund of the surplus

Payout as a tax refund when the tax burden is exceeded

If the assessed allowance is larger than the tax, the tax office transfers the difference. That surplus is what makes the Research Allowance payout in case of a loss valuable for growth companies, and it is the point at which money actually moves rather than being netted off.

A mechanical engineering SME with EUR 1.2 million of its own R&D wages and EUR 400,000 of eligible contract research reaches an allowance of EUR 560,000 at 35 percent. Against an assessed tax of EUR 180,000, that leaves EUR 380,000 to be transferred.

When does the tax office pay out the Research Allowance?

The decisive trigger is not the BSFZ certificate alone, but the tax assessment for the relevant year. Delayed annual financial statements directly cost months of liquidity here.

Step by step: From application to payout

The R&D project goes to the BSFZ first, the Bescheinigungsstelle Forschungszulage, which examines whether the work counts as basic research, industrial research or experimental development in the sense the tax law uses those terms.

What the file has to contain is unglamorous, and it is where most of the value is won or lost.

  • BSFZ certificate per project
  • Time and activity records of the R&D personnel
  • Payroll documents, project lists, and contract documents
  • Evidence on contract research and the assets used
  • Records of the remaining eligible expenses, which carry a 20 percent overhead lump sum for projects starting after 31 December 2025, so from 2026 onwards

After submission via ELSTER the tax office issues a Research Allowance assessment notice. The money follows with the next tax assessment, not separately from it.

Typical timeframe and possible delays

In well-organised structures a payout a few months after the tax return is realistic. A lag of up to 12 months is not unusual either, and the causes repeat: unclear project boundaries, missing personnel documentation, or queries going back and forth between the tax office and the tax department.

For predictable results, keep a fixed annual calendar: apply to the BSFZ early, record costs monthly, write down technical uncertainties while they are still fresh, and file the return straight after the annual accounts.

The Research Allowance and tax liability: Is the funding tax-free?

Is a Research Allowance tax-free?

Yes, in effect it is tax-free. The allowance is not treated as business income and is not taxed a second time under income tax or corporate income tax. Section 10 FZulG credits it against the assessed tax and refunds the surplus, and no further tax falls on that amount.

Accounting treatment: How the Research Allowance is correctly recorded

How the allowance is booked depends on the legal form and the accounting standard. What matters is the accrual-based recognition of the claim and the correct link to tax expense and refund receivable. Under IFRS, or where several funding instruments run in parallel, settle the classification with the tax adviser and the auditor early.

Avoiding common mistakes in the Research Allowance payout

Many delays have nothing to do with how innovative the work is; they come from thin documentation. The Research Allowance does not fund general product development, it funds systematic R&D with technological risk. Routine adjustments, customisation for a single customer or market-driven releases invite queries and reductions.

Mistakes in the application to the tax office via ELSTER

The ELSTER application fails in fairly predictable places.

  • Diverging annual figures between HR, accounting, and the tax department
  • Missing separation of funded and non-funded periods
  • Lump-sum expense estimates without time logic
  • Unclear contractual situation for contract research

The countermeasures are unspectacular, and they work.

  • A uniform project code for HR, finance, and R&D
  • Monthly time recording instead of annual reconstruction
  • Short technical reports on uncertainties and iterations
  • Contract review for external research before the project start

In biotech and pharma the hard line runs between eligible experimental development and the regulatory work that follows a known protocol. Teams that build that boundary into their project structure from the start, with separate cost centres and separate reporting, rarely have to argue about it years later.

What to do if the payout is delayed?

If the refund fails to materialise, check where the procedure actually stands: is the Research Allowance assessment notice there, has the tax return been fully processed, are queries from the tax office still open? Missing documents then go in as one structured submission rather than in instalments.

If longer delays are emerging, do not build the financing plan on the expected refund alone. The Research Allowance can run alongside other public funding for the same R&D project, but Section 7 FZulG excludes from the assessment basis any expenses that another programme, EU funding included, already covers. The two have to be kept apart cost by cost, and a second instrument running in parallel is usually more robust than waiting on one assessment.

Conclusion: How to get the maximum out of the Research Allowance

In 2026 the Research Allowance payout in Germany is a predictable liquidity instrument, without dilution and without repayment. SMEs work with a 35 percent rate and an assessment basis of EUR 12 million per fiscal year, which puts the maximum allowance at EUR 4.2 million, inside a process that ties the BSFZ certificate, the cost documentation and the tax assessment together. Document the R&D personnel costs properly, evidence the technological uncertainty, and file the corporate income tax or income tax return early, and the refund becomes something you can plan with, year after year, without giving up equity.

Articles by Kirill Rubinstein
Kirill Rubinstein
Kirill Rubinstein Founder of BeFunded

Kirill is the founder of BeFunded, a consultancy helping German businesses secure R&D funding. With 20+ years of experience in the German funding landscape, he guides startups and SMEs through programs like ZIM and Forschungszulage.

View profile LinkedIn
Talk to us

Ask us anything.

Tell us about your project and we'll assess your case by hand, no prep, no obligation.